Atomoxetine is a non-stimulant medication used to treat ADHD by increasing the levels of norepinephrine in the brain. It helps improve attention span and reduce impulsivity and hyperactivity. This active ingredient is found in several high-quality generic alternatives that offer effective management of ADHD symptoms. Our pharmacy ensures access to consistent and authentic medications containing Atomoxetine for patients across the UK.
Atomoxetine is a medication that belongs to the class of norepinephrine re-uptake inhibitors. It is designed to affect brain chemistry in a way that helps improve attention and reduce impulsive behaviour. In the United Kingdom, atomoxetine is available under the brand name Strattera as well as in generic form simply called atomoxetine.
The two main products you will see on pharmacy shelves are Strattera and the generic atomoxetine tablets. Both are supplied as oral tablets that can be taken once or twice a day, depending on the product’s formulation. Strattera is marketed by Eli Lilly and is the most widely recognised brand, while the generic version is produced by several different manufacturers and may be priced differently. Strengths typically range from 10 mg to 100 mg per tablet, allowing prescribers to tailor the dose to each individual’s needs. All of these medicines are prescribed only after a professional assessment, and they are listed on the NHS formulary for the conditions they treat.
Atomoxetine is primarily used to manage attention-deficit/hyperactivity disorder (ADHD) in children, teenagers and adults. ADHD is a neurodevelopmental condition characterised by difficulty sustaining attention, excessive activity, and impulsive actions that can interfere with daily life. By influencing the levels of norepinephrine in the brain, atomoxetine can help improve concentration and lessen hyperactive or impulsive tendencies.
Other situations where doctors may consider atomoxetine include:
These uses are based on clinical experience and the guidance of regulatory bodies such as the Medicines and Healthcare products Regulatory Agency (MHRA).
When taken, atomoxetine blocks the re-absorption of norepinephrine, a natural chemical that helps regulate attention and impulse control. By keeping more norepinephrine available in the brain, the medication supports steadier focus and reduces the urge to act without thinking. Effects are usually noticed within a few weeks, but the full benefit may take longer as the brain adjusts to the new balance.
Most people experience only mild, short-lasting reactions. Typical reports include:
These symptoms often lessen as the body becomes accustomed to the treatment.
Although rare, some reactions require immediate attention:
If any of these occur, seek urgent medical care.
People with certain health conditions may need extra monitoring:
Pregnancy and breastfeeding considerations are handled on an individual basis, and the prescribing professional will weigh the benefits against any potential risks.
Atomoxetine can interact with other medicines, especially:
Lifestyle factors such as driving or operating machinery should be approached with caution until you know how the medication affects you. Detailed interaction lists are provided on each product’s official leaflet.
Store tablets in a cool, dry place away from direct sunlight and out of reach of children. Do not refrigerate unless the label specifically says so. Treatment duration varies: some people use atomoxetine for a few months while others continue for several years, depending on how well it controls symptoms. Always read the patient information leaflet that comes with your specific product and follow the instructions given by the prescriber. For detailed usage, dosing, administration, refer to your specific medication's information.
Norepinephrine re-uptake inhibitor: A type of drug that stops the brain from quickly re-absorbing norepinephrine, keeping more of the chemical available to help with focus and impulse control.
Attention-deficit/hyperactivity disorder (ADHD): A condition marked by inattention, hyperactivity, and impulsivity that can affect learning, work and relationships.
Extended-release: A formulation designed to release the active ingredient slowly over time, allowing once-daily dosing for many patients.
This article provides general educational information about atomoxetine as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing atomoxetine may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
